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Introduction: Staphylococcus aureus has emerged as a major nosocomial pathogen in the last decades and also
represents the second most common pathogen isolated from patients in outpatient settings. Although
methicillin-resistant S.aureus infections were traditionally limited to hospitals, community-associated cases of
methicillin-resistant S.aureus infections have been reported. In our case, we observed an unexpected event during
treatment.
Case presentation: A 60-year-old Caucasian man developed fever and multiple muscle and brain abscesses caused
by Panton-Valentine leukocidin-negative community-associated methicillin-resistant S. aureus.
Conclusion: Although our patient was given antimicrobials active against the isolated methicillin-resistant S. aureus
strain, it was only after the introduction of daptomycin that his skin, soft tissue and muscle lesions and also brain
manifestations improved.Introduction
Staphylococcus aureus (SA) has emerged as a major no-
socomial pathogen in the last decades and also repre-
sents the second most common pathogen isolated from
patients in outpatient settings [1]. SA is commonly carried
asymptomatically in human anterior nares and occasio-
nally enters the bloodstream to cause invasive diseases
with a wide range of syndromes, from minor skin and soft
tissue infections to life-threatening necrotizing pneumonia
and toxic shock syndrome [1]. The overall burden of
staphylococcal diseases caused by antibiotic-resistant SA,
particularly by methicillin-resistant S. aureus strains
(MRSA), is increasing in several countries, including Italy,
where MRSA accounts for 25% to 50% of all hospital-
isolated SA strains and causes 52.8% of intensive care unit
(ICU)-acquired infections [2].* Correspondence: taglietti.f@gmail.com
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reproduction in any medium, provided the orAlthough MRSA infections were traditionally limi-
ted to hospitals, community-associated cases of MRSA
(CA-MRSA) infections have been reported since the late
1990s in the USA [3]. CA-MRSA strains are genetically
and phenotypically distinct from the typical multidrug-
resistant healthcare-associated MRSA. These strains are
resistant to beta-lactam antibiotics, are typically suscepti-
ble to other anti-staphylococcal agents, and often encode
for Panton-Valentine leukocidin (PVL) and other exoto-
xins and virulence factors [4].
The vast majority of CA-MRSA carry one of two smaller
staphylococcal cassette chromosome mec(SCCmec) types,
IV and V, without the additional resistance genes, and thus
are in general more susceptible to non-beta-lactam anti-
biotics. They appear to be associated with increased trans-
mission and hospitalization, skin and soft tissue infection
and, rarely, severe diseases including necrotizing pneumo-
nia [5]. CA-MRSA strains have rapidly emerged world-
wide and are now endemic in the USA where they
are amongst the most commonly isolated pathogens
in emergency departments. Furthermore, nosocomiall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recently been observed in several countries [6].
Very few cases of infections due to CA-MRSA are
reported in Italy [7]. We describe a case of multiple
muscle and brain abscesses, caused by an MRSA encoding
SCCmec IV, in an apparently immunocompetent patient.
Case presentation
A 60-year-old Caucasian male retired nurse was admit-
ted three years ago to our Infectious Diseases Hospital
because of a three-day history of ingravescent dyspnoea,
a skin abscess on his left arm and a very high fever. He
had a past medical history of arterial hypertension, is-
chemic cardiomyopathy, cholecystectomy, lumbar discal
hernia self-treated with steroids in case of lumbar pain,
and an allergy to ceftriaxone.
Thirteen days prior to the present admission, our pa-
tient was admitted to an emergency room of another
hospital for more severe lumbar pain; there he received
intravenous steroids that improved his pain, and he was
discharged on the same day. After three days, he con-
sulted his general practitioner because of fever and the
swelling of his left arm where a peripheral intravenous
line was located during his previous emergency admis-
sion. With the suspicion of phlebitis, he was given pipe-
racillin and calciparine for seven days. However, due to
the persistence of the fever and arm swelling and the
onset of dyspnoea, one week later he was admitted to a
general hospital. His blood pressure was 100/60mmHg,
pulse rate 120beats/min and temperature 39.5°C. Phy-
sical examination revealed right basal chest crepitations
and an abscess on his left arm. Blood examinations
showed a white blood cell count of 9.2 per mm3 with
76% neutrophils, C-reactive protein 58mg/dL (normal
value <0.60mg/dL), erythrocyte sedimentation rate of 90
(normal value 0-12mm/h) and glycemia of 456mg/dL.
Red blood cells, platelet counts, and the other blood
examinations were normal. A chest X-ray showed a right
basal consolidation. On the second day of admission, his
skin abscess was surgically drained, yielding S. aureusFigure 1 Computed tomography of the brain and thorax.with a vancomycin minimum inhibitory concentration of
1μg/mL. On the same day, our patient developed chest
pain and was admitted to the cardiologic ICU for an in-
ferior ST segment elevation myocardial infarction.
On day 4, his clinical conditions worsened and our pa-
tient presented with seizures: total-body computerized
tomography showed multiple cerebral lesions described
as brain abscesses, right pneumonia and scapular soft
tissue abscesses (Figure 1). Blood cultures were then per-
formed. He was started on imipenem (500mg intrave-
nously three times a day), ciprofloxacin (200mg twice
daily) and teicoplanin (200mg once daily).
On day 5, because of persisting fever and dyspnoea,
our patient was transferred to the ICU of our Infectious
Disease Institute. At the moment of ICU admission, he
was febrile (39.8°C), confused and dyspnoic: blood and
draining cultures were performed, and empiric antibiotic
therapy, including meropenem (1g intravenously three
times per day), linezolid (600mg intravenously twice daily)
and levofloxacin (500mg intravenously twice daily),
was started. Urinary antigen tests for Legionella and
Streptococcus pneumoniae were negative.
His fever still persisted by day 6. A vertebral nuclear
magnetic resonance (NMR) imaging study was negative
for spondylodiscitis and transthoracic echocardiography
showed no endocardial vegetations. On day 7, another
surgical drainage of his left arm and scapular soft tissue
abscesses was performed. His clinical condition was
stable. Both the blood cultures and swabs performed in
our Infectious Diseases Hospital yielded MRSA.
Both strains of SA isolates were methicillin-resistant.
Molecular characterization was conducted by polyme-
rase chain reaction of mecA, pvl and major enterotoxin
content genes, SCCmec-typing and multilocus sequence
typing (MLST); pulsed-field gel electrophoresis (PFGE)
was used only to define possible relationships among the
isolates. All techniques were performed as previously
described [8,9]. Strains were identical, as demonstrated
by PFGE (data not shown) and belonged to the ST8
SCCmec IV.3. A further characterization to define the
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PVL-negative, but possessed different superantigen to-
xins (enterotoxins k, q, d, j and tst), all conferring the
hypervirulent behavior demonstrated by the strains. The
isolated strains were susceptible to rifampin, fluoroqui-
nolones, gentamicin, tetracycline and cotrimoxazole and
were also fully susceptible to glycopeptides, linezolid,
daptomycin, quinupristin/dalfopristin and tigecycline.
The SA strain isolated during the previous admission to
another hospital was not available to perform further
microbiologic analysis.
On day 12, a whole-body computed tomography
showed that the multiple brain abscesses previously
described had worsened, and new brain lesions were
evident. In addition, computed tomography showed the
presence of left basal pneumonia and the onset of new
multiple muscle abscesses (left deltoid, paravertebral, left
pectoral and right psoas, gluteal and iliac). A neurosurgery
consultation excluded the possibility of draining the brain
abscesses. Daily administration of daptomycin 6mg/kg
was started and the administration of meropenem was
interrupted.
On day 22, the clinical and radiologic findings im-
proved. Our patient became non-febrile, and erythrocyte
sedimentation rate and C-reactive protein decreased. On
day 38, a chest X-ray was normal, daptomycin and levo-
floxacin were interrupted, and our patient was dis-
charged in good general condition. Administration of
linezolid 600mg twice a day was continued for two
weeks. After a two-year period, our patient is still in
good health.Discussion
Skin and soft tissue and lower respiratory infections ac-
count for much of the current clinical literature about
CA-MRSA. We report the case of a patient with pneumo-
nia and multiple abscesses involving skin, soft tissue and
the central nervous system caused by a PVL-negative
CA-MRSA.
Notably, in our patient we observed a rapid onset and
dissemination of the infection and clinical severity, simi-
lar to cases of PVL-positive CA-MRSA infections already
described in the literature. Community-isolated strains,
not only the PVL-positive ones, can be considered one
of the most significant challenges of this epidemiological
change of SA. In fact, these CA-MRSA strains, even if
PVL negative, possess several virulence determinants re-
sponsible for more severe diseases than the nosocomial
clones. One of these virulence determinants of CA-MRSA
strains is represented by the presence of staphylococcal
superantigens that, as described in the literature, may be
related to steroid therapy [8]. Our patient, as seen in the
case report, had a history of lumbar discal herniation self-treated with steroids and the MRSA strain isolated pos-
sessed several superantigen toxins.
Although our patient was given antimicrobials that
were active against the isolated MRSA strain, namely
levofloxacin and linezolid, his clinical condition rapidly
worsened. A likely explanation is the bacteriostatic effect
of linezolid, the concentration-dependent activity of le-
vofloxacin [9] and an aggressive virulence of the MRSA
strain. In our case, the introduction of daptomycin in
the antimicrobial schedule allowed fast improvement
concerning skin, soft tissue and muscle lesions and also
brain manifestations. Indeed, daptomycin has been
shown to be effective in central nervous system infection
in humans and animal models [10,11].
Conclusions
CA-MRSA infection, even if PVL negative, can be ra-
pidly aggressive with multiple lesions, including in the
brain. Daptomycin seems to be effective in the treatment
of these severe cases owing to its pharmacokinetic and
pharmacodynamic characteristics and its fast bactericidal
activity with a limited bacterial lysis [12,13].
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